PGBHX | RGEBX | PGBHX / RGEBX | |
Total Expense Ratio | 0.57 | 1.09 | 52% |
Annual Report Gross Expense Ratio | 0.60 | 1.09 | 55% |
Fund Existence | 9 years | 11 years | - |
Gain YTD | 11.331 | 15.398 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.5B | 332B | 3% |
Annual Yield % from dividends | 0.10 | 0.00 | - |
Returns for 1 year | 14.46 | 17.59 | 82% |
Returns for 3 years | 71.10 | 57.61 | 123% |
Returns for 5 years | 53.42 | 38.71 | 138% |
Returns for 10 years | N/A | 91.44 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MUU | 26.19 | 2.71 | +11.54% |
Direxion Daily MU Bull 2X Shares | |||
WLTG | 33.62 | -0.02 | -0.07% |
WealthTrust DBS Long Term Growth ETF | |||
IQSU | 51.58 | -0.12 | -0.24% |
NYLI Candriam U.S. Large Cap Equity ETF | |||
ILCB | 89.77 | -0.26 | -0.29% |
iShares Morningstar U.S. Equity ETF | |||
BIS | 13.46 | -0.48 | -3.41% |
ProShares UltraShort Nasdaq Biotech |